L&S Knock-Out QSC/ DE000LS63X44 /
| 2024-05-28 11:00:17 AM | Chg.+0.010 | Bid1:17:15 PM | Ask1:17:15 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 0.390EUR | +2.63% | 0.400 Bid Size: 8,000 |
0.430 Ask Size: 8,000 |
Q.BEYOND AG | 0.488 - | 2078-12-31 | Call |
GlobeNewswire
4:52 PM
Paperclip to Showcase SAFE® Searchable Encryption at Gartner Security & Risk Management Summit 2024
GlobeNewswire
4:28 PM
AmeriCorps Introduces Transformative Rule to Boost Grant Flexibility and Empower National Service Pr...
GlobeNewswire
4:24 PM
Porsche teams up with ESL FACEIT Group for DreamHack Dallas, Overwatch® Championship Series
GlobeNewswire
4:00 PM
Urban Grid Launches Local Scholarship Program in Virginia, Pennsylvania and Maryland, Boosting Workf...
GlobeNewswire
3:35 PM
SCHMID Group Takes Next Step Towards Advanced Packaging for Integrated Circuits with Glass Cores
GlobeNewswire
3:20 PM
C3is Inc. reports Revenue of $12.8 million, Net Income of $3.8 million, and financial and operating ...
Newsfile Corp
3:00 PM
Ocode and Akeneo Join Forces to Help Brands Implement the DPP (Digital Product Passport)
GlobeNewswire
3:00 PM
Castor Maritime Inc. Announces the Completion of the Sale of the M/V Magic Horizon
GlobeNewswire
3:00 PM
5E Advanced Materials Announces Agreement to Sell $6 Million of Additional Convertible Notes
GlobeNewswire
2:53 PM
InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. In...
GlobeNewswire
2:30 PM
Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Dist...
GlobeNewswire
2:30 PM
Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depre...
GlobeNewswire
2:15 PM
Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclu...
GlobeNewswire
2:05 PM
Outlook Therapeutics® Receives European Commission Marketing Authorization for LYTENAVA™ (bevacizuma...
